Kneat.com, Inc.
TSX:KSI.TOMedical - Healthcare Information Services
-$0.01 today
- Market cap
- $624.86M
- Beta
- 1.37
- P/E (TTM)
- -73.0
- EPS (TTM)
- -$0.09
Volume 0.10M
Average 0.31M
KSI.TO Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Kneat.com, Inc.TSX: KSI.TO
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development declines year over year
Q1 FY2026 research & development of CA$3.19M fell 32.2% year over year, behind the -25.6% change in trailing-twelve-month research & development. Sequentially, it rose 61.6% from the prior quarter. Over 3 fiscal years it compounded at -7.0% a year.
Context
- Research & development amounted to 14.0% of revenue in FY2025, down 21.3 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -32.2% toward the trailing-twelve-month pace of -25.6%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
CAD · from the income statement
- Latest · FY2025
- 8.84M CAD
- Year-over-year change
- -48.8%
- 4-year CAGR
- +1.5%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 8.84M | -48.8% |
| FY2024 | 2024-12-31 | 17.27M | +9.5% |
| FY2023 | 2023-12-31 | 15.76M | +43.4% |
| FY2022 | 2022-12-31 | 10.99M | +32.0% |
| FY2021 | 2021-12-31 | 8.33M | — |
Research & Development vs competitors
How KSI.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -25.6% is the 4th highest of 6, against a peer median of +31.9%.
- Research & development amounts to 20.0% of revenue for KSI.TO, versus a peer median of 4.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$33.61M CAD | +45.4% | +25.2% | 6.6% | |
| LTM Mar 2026 | CA$32.77M CAD | +92.4% | +40.5% | 27.5% | |
| LTM Mar 2026 | CA$13.33M CAD | -25.6% | -7.0% | 20.0% | |
| LTM Mar 2026 | CA$4.85M CAD | +31.9% | -15.1% | 1.5% | |
| LTM Mar 2026 | CA$1.84M CAD | -59.9% | — | 66.7% | |
| LTM Mar 2026 | $0 USD | -100.0% | -39.8% | 0.0% | |
| LTM Mar 2026 | CA$0 CAD | — | — | 0.0% | |
| Peer median (excluding KSI.TO) | — | +31.9% | +5.1% | 4.1% | |
Competitors are the stored peer set for KSI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 15.5M | 23.75M | 34.22M | 48.94M | 63.26M |
| Cost of Revenue | 6.18M | 9.09M | 11.09M | 12.18M | 28.56M |
| Gross Profit | 9.32M | 14.65M | 23.13M | 36.76M | 34.7M |
| Gross Margin | 60.1% | 61.7% | 67.6% | 75.1% | 54.9% |
| Research & Development | 8.33M | 10.99M | 15.76M | 17.27M | 8.84M |
| Selling, General & Admin | 7.35M | 13.44M | 20.98M | 25.44M | 34.31M |
| Operating Expenses | 15.67M | 24.43M | 36.74M | 42.71M | 43.15M |
| Depreciation & Amortization | 4.44M | 5.7M | 7.61M | 10.13M | 13.99M |
| EBITDA | (5.11M) | (3.2M) | (5.37M) | 6.27M | 5.54M |
| EBITDA Margin | -33.0% | -13.5% | -15.7% | 12.8% | 8.8% |
| Operating Income | (6.35M) | (9.77M) | (13.53M) | (5.95M) | (8.45M) |
| Operating Margin | -41.0% | -41.2% | -39.5% | -12.2% | -13.4% |
| Interest Income | 6.45K | 2.75K | 6.64K | 678.39K | 516.74K |
| Interest Expense | 284.95K | 228.59K | 1.08M | 3.67M | 3.43M |
| Other Income / Expenses | (3.48M) | 642.86K | (529.44K) | (1.59M) | 6.26M |
| Income Before Tax | (9.84M) | (9.13M) | (14.06M) | (7.53M) | (2.19M) |
| Pre-Tax Margin | -63.5% | -38.5% | -41.1% | -15.4% | -3.5% |
| Income Tax Expense | 20.91K | 16.61K | 55.89K | 192.6K | 158.86K |
| Net Income | (9.86M) | (9.15M) | (14.12M) | (7.73M) | (2.35M) |
| Net Margin | -63.6% | -38.5% | -41.3% | -15.8% | -3.7% |
| EPS (Basic) | (0.13) | (0.12) | (0.18) | (0.09) | (0.02) |
| EPS (Diluted) | (0.13) | (0.12) | (0.18) | (0.09) | (0.02) |
| Weighted Avg Shares | 74.11M | 77.44M | 77.83M | 86.55M | 94.91M |
| Weighted Avg Shares (Diluted) | 74.11M | 77.44M | 77.83M | 86.55M | 94.91M |
Kneat.com, Inc.
TSX:KSI.TO
Intrinsic Alpha fair value
Locked
Current Price
$6.50
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.